AstraZeneca in the Vaccine Race; Ballots in Georgia

Squawk Pod

CNBC

Business News, Investing, Business, News

4 • 494 Ratings

🗓️ 23 November 2020

⏱️ 38 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

AstraZeneca’s Covid vaccine is the third one to prove highly effective in late-stage trials. AstraZeneca Executive Vice President Ruud Dobber explains differentiators of his company’s vaccine, and why between his company, Pfizer, and Moderna, he has high hopes for an accessible vaccine. New York Times columnist Thomas Friedman discusses the next steps in the race for a vaccine and in the Presidential transition. Plus, political pollster and strategist Frank Luntz unpacks what’s at stake on the ballots in Georgia.

Transcript

Click on a timestamp to play from that location

0:00.0	This is Squawk Pod. I'm C.N.C. producer Cameron Costa. Today on our podcast,
0:07.0	Another Shot in the Arm against COVID. A third vaccine showing 90% efficacy, head of AstraZeneca US on his company's big news.
0:17.8	Of course we are starting to create the herd immunity specialist.
0:22.2	We can only hope that together with fights in Modena and also
0:25.6	Azizanica we will manufacture enough doses in order to achieve that sooner than later.
0:31.1	Processing the news and the journey to come with New York Times columnist Tom Friedman.
0:36.7	It's really amazing what big pharma has done here to produce a vaccine for this virus in record time.
0:43.0	Plus, what's at stake in the Georgia Senate?
0:46.0	Well, maybe everything.
0:48.0	Political strategist Frank Luntz.
0:50.0	I would argue that what Donald Trump says and does over the next six weeks
0:54.8	is going to determine the outcome of the Georgia Senate race and well made to
0:59.5	determine the outcome of our country overall.
1:01.8	It's Monday, November 23rd, 2020. Squack Pod begins right now.
1:07.0	Good Monday morning everybody. Welcome to Squackbox. This is CMBBC. I'm Becky Quick along with Andrew Ross
1:13.9	Sorkin and Brian Sullivan. Good to see you Brian. Welcome. Great to have
1:17.4	everybody here with us this morning. Joe's out today. It's a Monday and
1:21.4	it's a Monday in November and that means we've got great news on the vaccine front.
1:25.0	It's the big news this morning that we've got to tell everybody about right now.
1:28.0	Yeah, it certainly is, Becky and good morning and it's great to be with you, especially when we have such good news.
1:33.0	And among that top story is late stage trials
1:36.0	showing the AstraZeneca-Oxford COVID vaccine
	...

Transcript will be available on the free plan in -1589 days. Upgrade to see the full transcript now.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.